Department of Endocrinology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Front Endocrinol (Lausanne). 2024 Apr 22;15:1369600. doi: 10.3389/fendo.2024.1369600. eCollection 2024.
The Metabolic Score for Insulin Resistance (METS-IR) offers a promising and reliable non-insulin-based approach to assess insulin resistance and evaluate cardiometabolic risk. However, evidence for the association between METS-IR and hypertension was still limited.
Participants from the National Health and Nutrition Examination Survey (NHANES) database from 2007-2016 were selected for weighted multivariable regression analyses, subgroup analyses and restricted cubic spline (RCS) modeling to assess the association between the METS-IR and hypertension, as well as systolic blood pressure (SBP) and diastolic blood pressure (DBP).
This study enrolled 7,721 adults aged ≥20 years, 2,926 (34.03%) of whom was diagnosed as hypertension. After adjusting for all potential covariates, an increased METS-IR (log conversion, denoted as logMETS-IR) was independently associated with a higher prevalence of hypertension (odd ratio [OR] 3.99, 95% confidence interval [CI] 3.195.01). The OR for hypertension in subjects with the highest quartile of METS-IR was 3.89-fold (OR 3.89, 95% CI 3.064.94) higher than that in those with the lowest quartile of METS-IR. This positive correlation became more significant as METS-IR increased ( for trend < 0.001). LogMETS-IR was significantly correlated with increase in SBP (β 6.75, 95% CI 5.657.85) and DBP (β 5.59, 95% CI 4.756.43) in a fully adjusted model. Consistent results were obtained in subgroup analyses. Hypertension, SBP and DBP all exhibited a non-linear increase with the rise in METS-IR. The minimal threshold for the beneficial association of METS-IR with hypertension, SBP and DBP were all identified to be 46.88.
The findings of this study revealed a significant positive association between METS-IR and hypertension among US adults, suggesting METS-IR as a potential tool for assessing hypertension risk.
胰岛素抵抗代谢评分(METS-IR)提供了一种有前途且可靠的非胰岛素基础方法,可用于评估胰岛素抵抗和评估心血管代谢风险。然而,关于 METS-IR 与高血压之间的关联证据仍然有限。
从 2007-2016 年的国家健康和营养检查调查(NHANES)数据库中选择参与者进行加权多变量回归分析、亚组分析和限制性立方样条(RCS)建模,以评估 METS-IR 与高血压以及收缩压(SBP)和舒张压(DBP)之间的关联。
本研究纳入了 7721 名年龄≥20 岁的成年人,其中 2926 人(34.03%)被诊断为高血压。在调整所有潜在混杂因素后,METS-IR 升高(log 转换,记为 logMETS-IR)与高血压的患病率升高独立相关(比值比[OR]3.99,95%置信区间[CI]3.195.01)。METS-IR 最高四分位数的受试者中高血压的 OR 为最低四分位数的 3.89 倍(OR 3.89,95%CI 3.064.94)。随着 METS-IR 的增加,这种正相关变得更加显著(趋势检验<0.001)。在完全调整的模型中,logMETS-IR 与 SBP(β6.75,95%CI 5.657.85)和 DBP(β5.59,95%CI 4.756.43)的增加显著相关。在亚组分析中也得到了一致的结果。高血压、SBP 和 DBP 均随着 METS-IR 的升高呈非线性增加。METS-IR 与高血压、SBP 和 DBP 有益关联的最小阈值均被确定为 46.88。
本研究结果表明,在美国成年人中,METS-IR 与高血压之间存在显著的正相关,提示 METS-IR 可能是评估高血压风险的一种潜在工具。